Clinical Trial Signal Monitor $49
Clinical trial desk · $49/month

Follow 25 trials. See when they move.

Search is free. Monitor is $49 a month. Your desk stores the last status, dates, and enrollment, then marks Changed when those fields move. Open the ClinicalTrials.gov record from the card.

How to use it

1

Search

Look up a drug, sponsor, condition, or ClinicalTrials.gov ID. The public feed and FDA cards stay free.

2

Subscribe to Monitor

$49 a month. Sign in with Google or Microsoft after checkout. Follow 25 trials on your desk.

3

Watch the desk

You see stored values first. Changed appears after status, dates, or enrollment move. No email.

What you get

Use it when you need to know whether a trial you already follow changed status, dates, or enrollment. You check the desk. You open the registry record. That is the product.

Enterprise platforms
Clinical Trial Signal
DataProprietary curated datasets
DataPublic-source monitoring
PricingAnnual contracts
PricingMonthly self-serve pricing
ScopeDeep pipeline / patent / regulatory / deal intelligence
ScopeDaily trial, safety, sponsor, literature, patent, and grant movement
Built forLarge-team workflows
Built forIndividual and small-team watchlists
Stack roleExpensive research stack
Stack roleSource-backed awareness layer

Live on the free feed

ClinicalTrials.gov FDA MedWatch openFDA recalls

EDGAR, patents, grants, and ex-U.S. registries are listed on the source map. They are not the free homepage feed.

Who this is for

Consultants

A brief a client can audit

What moved, the primary record, and the caveat. Not a curated pipeline database.
Small biotech and BD

Competitor timing without a contract

Watch Phase 2/3 industry programs and status reversals on a Monday morning email once you save a watchlist.
Specialist journalists

Public-record changes worth a call

Terminations, date slips, recalls, and FDA communications with a link to the source page.

What a signal looks like

Example signals. The cards below describe the shape of a signal from each source. Real signals on /trials, /safety, and /sponsors link directly to the primary public record.
Trial Movement Example signal Notable
Phase 3 GLP-1 obesity program — primary completion shifted
GLP-1 drug class · Phase 3 · Condition: Obesity
What changed. Registry record updated — primary completion moved later. Why it matters. Read-out timing shifts cascade through competitor positioning and analyst submission-timeline models.
Source type: ClinicalTrials.gov registry record Fields surfaced: status, primary completion date, last update posted
FDA / Safety Example signal High Attention
openFDA Drug Enforcement — Class II recall posted
openFDA Drug Enforcement · Recall class: II · Multiple lots
What changed. A Class II recall covering multiple lots was entered into openFDA enforcement records. Why it matters. Class II indicates temporary or reversible health consequences are possible; supply chains and prescribers track these closely.
Source type: openFDA Drug Enforcement endpoint Fields surfaced: classification, recall reason, lots, distribution pattern, status
Sponsor Disclosure Example signal Monitor
Public biotech sponsor — Form 8-K references FDA correspondence on Phase 2 program
SEC 8-K disclosure · Phase 2 oncology program · Sponsor-disclosed
What changed. A material-event filing reports receipt of FDA correspondence regarding the sponsor's Phase 2 program. Why it matters. Sponsor-disclosed FDA correspondence often precedes registry status changes by days to weeks.
Source type: SEC EDGAR Form 8-K filing Fields surfaced: item, filing date, narrative excerpt with FDA-correspondence reference
See live signals →

Live trial movement

Updated vs changed. A last-update date is not a field diff. Cards labeled Changed show previous and new values. Cards labeled Updated only have the current registry state.
Search any drug, sponsor, or condition →

Evidence Room

Every record we ship carries the same source-backed contract — the fields a researcher needs to verify, cite, and re-audit. If a field can't be filled from the primary record, the signal does not ship.

The source-backed contract
SourceNamed primary public source (e.g. ClinicalTrials.gov registry, openFDA enforcement, SEC 8-K)
Source URLDeep link to the specific primary record (NCT page, openFDA record, EDGAR filing)
Source timestampWhen the primary record reports the change
Ingested timestampWhen Clinical Trial Signal observed the change
Previous valueThe exact prior field value from the primary record
New valueThe exact new field value from the primary record
CaveatWhat the change does not establish (e.g. registry date moves do not establish cause; FAERS reports do not establish causation or incidence)
Evidence record Example evidence record Notable
Trial primary-completion change · Phase 3 GLP-1 obesity (illustrative)
SourceClinicalTrials.gov registry
Source URLDeep link to the live NCT record (shown on real signals)
Source published2026-05-30T00:00:00Z
Ingested2026-05-30T04:12:48Z
Previous valuePrimaryCompletion = 2026-12-15
New valuePrimaryCompletion = 2027-06-15
Normalized signaltrial.primary_completion_shift · delta = +6 months · severity = notable
AI-assisted interpretationA 6-month shift on a lead Phase 3 read-out moves the sponsor's regulatory submission window out of 2026, with downstream implications for competing-program timing and BD windows. Driver not disclosed in the registry record.
Registry date moves do not establish cause. Possible drivers include enrollment, supply, protocol amendments, analytical plan changes, or safety review. The sponsor has not publicly disclosed a reason in the registry record.

Why not enterprise platforms?

Clinical Trial Signal is not a proprietary curated enterprise database. It is a lower-cost public-record movement layer — built to detect what changed in public sources, generate source-backed briefs you can hand to a colleague or client, and tell you where deeper, paid-database research is actually worth the effort. Enterprise platforms still own deep curated pipeline / patent / regulatory / deal datasets; we sit beside them as an awareness layer, not a replacement.

Choose your tier

Free

Browse public records

Search ClinicalTrials.gov. See FDA MedWatch and openFDA recall cards.
Search trials
Monitor · $49/mo

Follow 25 trials

Desk stores current values and marks Changed when status, dates, or enrollment move.
Choose Monitor
Pro · $199/mo

Follow 50 trials

CSV of your desk. PubMed, openFDA, and EU CTIS for the trials you follow.
Choose Pro

Pricing

Free
$0

Public search and FDA cards. No saved list.

Pro · $199/mo
$199/month

Follow 50 trials. CSV. PubMed, openFDA, and EU CTIS.

Compliance-safe positioning. Clinical Trial Signal provides public-data research intelligence. It is not medical advice, legal advice, regulatory advice, investment advice, or a pharmacovigilance system of record. Public adverse-event data may be incomplete, duplicated, unverified, and cannot establish causation or incidence. Signals are intended for research screening and should be reviewed by qualified professionals.